Drug group definition

Drug group means a group of drugs defined by the division for
Drug group means a group of similar drugs specified by the Department of Health for the purpose
Drug group means a group of drugs defined by the division for the purpose of facilitating revenue and cost reporting by manufacturers, carriers, pharmacy benefits managers, and wholesalers under sections 2 through 6 of P.L.2023, c.106 (C.45:14-82.3 through 45:14-82.7).

Examples of Drug group in a sentence

  • The rates at which scripts were written for the groupings listed in Table 10.9 were generally between one-third and one-half of problems treated.Table 10.7 Infections: agents for systemic use – sub-groups Drug group (level 1) Sub-group (level 2)Percent of all script itemsPer 100 visitsPercent of drug group* Includes drug sub-groups comprising ≥ 1% of all script items.

  • If the EAIR is similar between the All Drug group and the placebo group, it cannot be used as evidence towards a lack of differencebetween treatment and placebo.

  • Table 10.25: Blood and blood-forming organs drugs: sub-groups Drug group (level 1) Sub-group (level 2)Percent of all script itemsPer 100 visitsPercent of drug group* Includes drug sub-groups comprising ≥ 1% of all script items.

  • In other hours, one-fifth of eye problems were treated in this manner (Table 10.39).Table 10.37 Sensory organ drugs: sub-groups Drug group (level 1) Sub-group (level 2)Percent of all script itemsPer 100 visitsPercent of drug group* Includes drug sub-groups comprising ≥ 1% of all script items.

  • Drug group Figure 5: Original thoracic EP bundles (Authors: Mr C Bond, Mr R Wotton, Mr B Naidu) However, these needed revising to ensure regular prescription of anti-emetics and laxatives to improve inpatient experience and reduce delayed discharge.

  • Most scripts were written for chronic obstructive airways disease, with fewer than one-third of problems being so treated (Table 10.36).Table 10.34 Systemic hormone drugs: sub-groups Drug group (level 1) Sub-group (level 2)Percent of all script itemsPer 100 visitsPercent of drug group* Includes drug sub-groups comprising ≥ 1% of all script items.

  • Juli Jurgens from the Office of the Chief Information Officer and her team are making great progress and are also doing a good job at keeping in constant contact with staff.

  • Reinvestment in organised crime by drug group and user type Drug group Amphetamine-type stimulants 34.0 42.4 3.8 4.8 8.6 Cannabinoids 323.7 225.1 36.3 25.2 61.5 Hallucinogenic and psychedelic drugs 0.2 1.6 0.02 0.2 0.2 Opioid and sedative drugs 1.0 1.0 0.1 0.1 0.2 Total 358.9 270.1 40.2 30.3 70.4 Over $70 million in funding for other criminal activities is provided each year from drug trafficking.

  • Table 10.40 Prescribing rates for different drug groups (script items per 100 visits) Drug group (PharmacodeslATC level 1)M−F, 8 am−6 pm (N = 590)Other hours (N = 840)16.

  • Over two-thirds of duodenal problems were so treated across both time periods, but otherwise these treatment rates were relatively low (Table 10.24).Table 10.22 Alimentary system drugs: sub-groups Drug group (level 1) Sub group (level 2)Percent of all script itemsPer 100 visitsPercent of drug group* Includes drug sub-groups comprising ≥ 1% of all script items.

Related to Drug group

  • GCP means the Good Clinical Practices officially published by EMA, FDA and the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) that may be in effect from time to time and are applicable to the testing of the Compounds.

  • Drug Master File or “DMF” is described in 21 C.F.R. Part 314.420. A DMF is a submission to the FDA that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.

  • Clinical peer means a physician or other health care professional who holds a non-restricted license in a state of the United States and in the same or similar specialty as typically manages the medical condition, procedure or treatment under review.

  • Xxxx Group means collectively Xxxx Capital Fund V, L.P., Xxxx Capital Fund V-B, L.P., BCIP Associates, BCIP Trust Associates, L.P. and Xxxxxxxx Street Partners.

  • Drug abuse means any pattern of pathological use of drugs that causes impairment in social or occupational functioning, or that produces physiological dependency evidenced by physical tolerance or by physical symptoms when it is withdrawn.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Licensed clinical social worker means an individual who meets the licensed clinical social worker requirements established in KRS 335.100.

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Xxxxx Group means Xxxxx and any Affiliate of Xxxxx.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Clinical Data means the information concerning the safety or performance that is generated from the use of a device and that are sourced from the following:

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Drug store means a place whose principal business is, the

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Multiregional Modeling Working Group or “MMWG” shall mean the NERC working group that is charged with multi-regional modeling.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Participating Clinical Social Worker means a Clinical Social Worker who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Xxxxxx Group shall have the meaning set forth in Section 9.2(b) hereof.

  • Drug outlet means a pharmacy, nursing home, shelter home, convalescent home, extended care facility, drug abuse treatment center, penal institution, hospital, family planning clinic, student health center, retail store, wholesaler, manufacturer, mail-order vendor or other establishment with facilities located within or out of this state that is engaged in dispensing, delivery or distribution of drugs within this state.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Clinical Development means the conduct of clinical trials in humans to assess the dosing, safety and/or efficacy of the Product, including but not limited to Phase I Clinical Trials, Phase II Clinical Trials, Phase Ill Clinical Trials and Phase IV Clinical Trials.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Drug test means a test designed to detect the illegal use of a controlled substance.